RodrÃguez-Lobato, L.G.; Tovar, N.; de Daniel, A.; Fernández de Larrea, C.; Cibeira, M.T.; Jiménez-Segura, R.; Moreno, D.F.; Oliver-Caldés, A.; Bladé, J.; Rosiñol, L.
Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution. Cancers 2023, 15, 5261.
https://doi.org/10.3390/cancers15215261
AMA Style
RodrÃguez-Lobato LG, Tovar N, de Daniel A, Fernández de Larrea C, Cibeira MT, Jiménez-Segura R, Moreno DF, Oliver-Caldés A, Bladé J, Rosiñol L.
Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution. Cancers. 2023; 15(21):5261.
https://doi.org/10.3390/cancers15215261
Chicago/Turabian Style
RodrÃguez-Lobato, Luis Gerardo, Natalia Tovar, Anna de Daniel, Carlos Fernández de Larrea, M. Teresa Cibeira, Raquel Jiménez-Segura, David F. Moreno, Aina Oliver-Caldés, Joan Bladé, and Laura Rosiñol.
2023. "Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution" Cancers 15, no. 21: 5261.
https://doi.org/10.3390/cancers15215261
APA Style
RodrÃguez-Lobato, L. G., Tovar, N., de Daniel, A., Fernández de Larrea, C., Cibeira, M. T., Jiménez-Segura, R., Moreno, D. F., Oliver-Caldés, A., Bladé, J., & Rosiñol, L.
(2023). Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution. Cancers, 15(21), 5261.
https://doi.org/10.3390/cancers15215261
